chartexchange

RGBPP
REGEN BIOPHARMA PFD A
stockOTCPreferred Stock

EODOct 1, 2026
0.0015USD-21.053%(-0.0004)3,877,263
Loading…
Loading…
Healthcare
Biotechnology
HQ
La Mesa, CA, USA
Previous Close
$0.00
Beta
0.72
52-Week High
$0.19 2025-10-28
52-Week Low
$0.00 2026-09-11
SMA 50
$0.00
SMA 200
$0.01
Avg. Vol 10D
530,922
Avg. Vol 30D
441,769
Avg. Vol 90D
251,656
Relative Vol
8.78
47.31M
36,017
Jul 5, 2024 · 3-for-1
RGBPP Profile

regen biopharma, inc. focuses on the development of small molecule therapies for treating cancer and autoimmune disorders in the united states. the company intends to develop small molecule nr2f6 that activates to immune cell for oncology and autoimmune diseases. the company was founded in 2012 and is based in la mesa, california. regen biopharma, inc. is a subsidiary of bio-matrix scientific group, inc.

RGBPP Performance
PeriodPriceDateChangeBeta
1W0.002026-09-28-25.00%-18.495
1M0.002026-09-04-40.00%5.054
3M0.002026-07-06-21.05%1.318
6M0.002026-04-06-57.14%0.401
1Y0.052025-10-06-96.88%0.719
2Y0.202024-10-04-99.25%—
5Y36.852021-10-05-100.00%-0.521
RGBPP Stock Summary

REGEN BIOPHARMA PFD A (OTC:RGBPP) stock price today is $0.00, and today's volume is 3,877,263. RGBPP is down 21.053% today. The 30 day average volume is 441,769. RGBPP market cap is $15,186 with 10.12M shares outstanding.